ArticleNephrology (Carlton, Vic.)2026
Multicystic Kidney Disease in a Family With Tuberous Sclerosis Complex.
Article in Nephrology (Carlton, Vic.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberous sclerosis complex (TSC) is a multisystem condition associated with disease-causing variants of either TSC1 or TSC2 genes. Significant kidney involvement in TSC is most often due to development of angiomyolipomas (AMLs) and occurs more frequently in people with TSC2 variants. Kidney cysts are also commonly seen; however, these are usually small and not recognised as problematic. A subset of patients has a severe polycystic kidney disease due to a contiguous gene deletion involving PKD1 and TSC2 on chromosome 16. End-stage kidney disease (ESKD) occurs commonly in patients with TSC2/PKD1 deletions but is otherwise rare. We report a family with a TSC1 variant. The father, a 34-year-old male, presented with chronic kidney disease with eGFR 31 mL/min, proteinuria 1.2 g/day and hypertension. Ultrasound showed small cystic kidneys. Coincidentally, his 2-year-old daughter presented with seizures and had skin lesions and neurological signs consistent with TSC. Her 1-year-old brother also met TSC diagnostic criteria. Further investigations of the father showed typical skin lesions and cerebral tubers. Genetic testing identified a variant in TSC1. The father progressed to ESKD and subsequently received a kidney transplant. His two children have similar renal ultrasounds with multiple cysts; now aged 18 and 16 years, they have normal eGFR and no proteinuria. This family manifests a rarely described multicystic phenotype and TSC1 variant. The father's case demonstrates the risk of progressive kidney disease in TSC, even in the absence of AMLs or TSC2/PKD1 contiguous deletion, and highlights the importance of renal monitoring of all adults with TSC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.